Navigation Links
Interventional Pulmonology Creeping into Bronchoscopy Market
Date:4/7/2008

Interventional Pulmonology is expected to increase the bronchoscopy market to approximately $180 million in 2012, according to Millennium Research

Group

WALTHAM, Mass., April 7, 2008 /PRNewswire/ -- According to Millennium Research Group's US Markets for ENT & Bronchoscopy 2008 report, an emerging field -- interventional pulmonology -- is creeping into the bronchoscopy market, and is expected to grow the overall market to $180 million by 2012.

To date, the majority of bronchoscopy procedures have been performed to diagnose pulmonary conditions such as lung cancer and chronic lung disease. A number of medical devices that can be used to treat lung-related conditions are, however, awaiting FDA approval. If these therapeutic devices are approved, bronchoscopy procedure volumes in the US will expand as pulmonologists and thoracic surgeons gain the ability to both diagnose and treat lung-related conditions using minimally invasive techniques. Because many interventional pulmonology procedures will be performed with a flexible bronchoscope, therapeutic device approval will also fuel demand for flexible bronchoscopes and other conventional bronchoscopy devices.

Asthmatx' Alair System, which was developed to treat severe asthma cases, will be submitted for FDA premarket approval in 2008. Its approval will add bronchial thermoplasty to the list of treatments that can be performed with flexible bronchoscopy.

"To date, clinical studies performed with the system have showed favorable results," says Tiffanie Demone, Analyst at Millennium Research Group. "A study published in the New England Journal of Medicine in March 2007 found that patients who underwent a bronchial thermoplasty used less rescue medication such as that found in inhalers and showed improvements to their quality of life. Moreover, there were almost 2.5 million severe asthma patients in the US in 2007 who could potentially benefit from bronchial thermoplasty."

The US Markets for ENT & Bronchoscopy 2008 report provides coverage of key industry competitors, including Arthrocare, Boston Scientific, Medtronic, and Olympus.

About Interventional Pulmonology

Interventional pulmonology is the treatment of breathing-related disorders such as asthma, lung cancer, chronic obstructive pulmonary disease, and emphysema. Paralleling the interventional cardiology market in the 1980s, the development of interventional pulmonology is changing the role of a pulmonologist from diagnostician to therapeutic interventionalist. A number of interventional pulmonology device developers formed over the last few years, including Emphasys Medical, Asthmatx, Spiration, Pulmonx, PneumRx, and superDimension. The approval and adoption of medical devices developed by these companies will expand the interventional pulmonology market in the coming years.

About Millennium Research Group

Millennium Research Group (http://www.MRG.net), a Decision Resources, Inc. company (http://www.DecisionResources.com), is the global authority on medical technology market intelligence and a leading provider of strategic information to the health care sector. Focused solely on the medical device, pharmaceutical, and biotechnology industries, the company provides its clients with the benefits of its specialized industry expertise through published reports and customized consulting services.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Amy Krohn

Millennium Research Group

416-364-7776 x101

akrohn@mrg.net


'/>"/>
SOURCE Millennium Research Group
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. See More, Do More: Siemens Highlights New Generation of Interventional Imaging Systems for Cardiology at ACC
2. Safe at Any Age: Octogenarians Do As Well as Younger Patients With Interventional Radiology Arterial Procedures
3. New Interventional Radiology Treatment Shows Hope for People With Complications from Bone Marrow, Stem Cell Transplants
4. Register Now for Interventional Radiology Meeting Press Conferences
5. SCAI Announces New Program to Support Interventional Cardiology Training Fellowships
6. Siemens Introduces Its New Generation of Artis Interventional Imaging Systems
7. Stereotaxis Showcases Interventional Cardiology Capabilities of Niobe Magnetic Navigation System
8. Gorilla Receives State-Of-The-Art Treatment for Uterine Fibroids from Interventional Radiologists
9. SCAI and ACC announce new interventional cardiology meeting
10. Stereotaxis Appoints Senior Vice President of Global Marketing and General Manager for Europe
11. Biopure Receives Comment Letter From U.K. Regulatory Body on Marketing Application for Hemopure(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ProVest Insurance Group, a ... Miami, and Raleigh regions, is organizing an extended charity drive to benefit the ... chromosome abnormality. , After struggling since birth with several health challenges, T.J. was ...
(Date:10/13/2017)... Pa. (PRWEB) , ... October 13, 2017 , ... While ... dark poses a problem. Fortunately, an inventor from Austin, Texas, has identified a solution. ... to medication in darkness or restricted lighting. As such, it eliminates the need to ...
(Date:10/13/2017)... Las Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... of 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum ... CBD dose required and providing a CBD form that can be easily incorporated into ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Apple Rehab ... services, staged a mock evacuation of the facility as part of a disaster drill ... Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... New York, NY (PRWEB) , ... October 13, 2017 , ... ... most influential people in business to advocate for action towards gender equality at their ... 18,000 views from around the globe, and reached a social audience of over 3 ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... Oct. 4, 2017  According to the Centers for Disease Control and ... October . PhysicianOne Urgent Care is helping communities across Massachusetts ... , by offering no-cost* flu shots through the end of the ... certain health insurance regulations. ... time to get a flu shot is by the end of October, ...
(Date:10/2/2017)... FLINT, Mich. , Oct. 2, 2017 ... acquired 8th Day Software and Consulting, LLC , ... 8th Day Software, based in Tennessee ... Management LLC. 8th Day expands EnvoyHealth,s service offerings for ... product development. "In ...
(Date:10/2/2017)... 2, 2017  AllianceRx Walgreens Prime, the combined central ... and pharmacy benefit manager Prime Therapeutics LLC (Prime), today ... included the unveiling of new signage at its headquarters ... as at a few other company-owned facilities across the ... patients, some of whom will begin to see the ...
Breaking Medicine Technology: